Amplification loop cascade for increasing caspase activity induced by docetaxel

Journal of Cellular Biochemistry

Volumn 96, Issue 4, 2005, Pages 810-820

  Cao, Dongxu ^a   Qiao, Bin ^a   Ge, Zhiqiang ^a   Yuan, Yingjin ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Caspase 3; Docetaxel; JNK SAPK; ROS

Indexed keywords

ACETYLASPARTYLGLUTAMYLVALYLASPARTALDEHYDE; AMINO ACID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE; CASPASE 3; CASPASE INHIBITOR; DIPHENYLIODONIUM SALT; DOCETAXEL; OXIDOREDUCTASE INHIBITOR; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN HL 60; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; CYTOSOL; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TAXOIDS; TRANSFECTION;

EID: 27644454763     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20563     Document Type: Article

References (37)

1. Bhalla KN. 2003. Microtubule-targeted anticancer agents and apoptosis. Oncogene 22:9075-9086.
2. Cao DX, Qiao B, Ge ZQ, Yuan YJ. 2004. Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett 214(1):103-113.
3. Choy H. 2001. Taxanes in combined modality therapy for solid tumors. Crit Rev Oncol Hematol 37:237-247.
4. Chung YM, Bae YS, Lee SY. 2003. Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34:434-442.
5. Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
6. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696.
7. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC. 2004. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: Evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 279:11957-11966.
8. Enomoto A, Suzuki N, Morita A, Ito M, Liu CQ, Matsumoto Y, Yoshioka K, Shiba T, Hosoi Y. 2003. Caspase-mediated cleavage of JNK during stress-induced apoptosis. Biochem Biophys Res Commun 306:837-842.
9. Goncalves A, Braguer D, Kamath K, Martello L, Briand C, Horwitz S, Wilson L, Jordan MA. 2001. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci USA 98:11737-11742.
10. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
11. Haldar S, Jena N, Croce CM. 1995. Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4504-4511.
12. Haldar S, Chintapalli J, Croce CM. 1996. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253-1255.
13. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
14. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)-From inflammation to development. Curr Opin Cell Biol 10:205-219.
15. Kolfschoten GM, Hulscher TM, Duyndam MC, Pinedo HM, Boven E. 2002. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel. Biochem Pharmacol 63:733-743.
16. Kroemer G, Dallaporta B, Resche-Rigon M. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619-642.
17. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW. 2000. Comparison of 2-methoxyestradiol-induced, docetaxel-induced and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89:983-994.
18. Martindale JL, Holbrook NJ. 2002. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192:1-15.
19. Michal PY, Drora H, Oded S, Ina F. 2004. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol 67:539-546.
20. Na S, Chuang TH, Cunningham A, Turi TG, Hanke JH, Bokoch GM, Danley DE. 1996. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol Chem 271:11209-11213.
21. Nishitai G, Shimizu N, Negishi T, Kishimoto H, Nakagawa K, Kitagawa D, Watanabe T, Momose H, Ohata S, Tanemura S, Asaka S, Kubota J, Saito R, Yoshida H, Mak TW, Wada T, Penninger JM, Azuma N, Nishina H, Katada T. 2004. Stress induces mitochondria-mediated apoptosis independent of SAPK/JNK activation in embryonic stem cells. J Biol Chem 279:1621-1626.
22. Osborn MT, Chambers TC. 1996. Role of the stress-activated c-jun NH2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeuticagents. J Biol Chem 271:30950-90955.
23. Park SJ, Wu CH, Gordon JD, Zhong XL, Emami A, Safa AR. 2004. Taxol induced caspase-10-dependent apoptosis. J Biol Chem 279:51057-51067.
24. Rowinsky EK. 1997. The development and clinical utility of taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353-374.
25. Sethi G, Sodhi A. 2004. Activation of c-Jun N-terminal kinase is required for ultraviolet B-induced apoptosis of murine peritoneal macrophages in vitro. J Photochem Photobiol B 73:133-140.
26. Simizu S, Takada M, Umezawa K, Imoto M. 1998. Requirement of caspase-3 (-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 273:26900-26907.
27. Stone AA, Chambers TC. 2000. Microtubule inhibitors elicit differential effects on MAP Kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp Cell Res 254:110-119.
28. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-879.
29. Toyoshima F, Moriguchi T, Nishida E. 1997. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK: SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J Cell Biol 139:1005-1015.
30. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J. 1998. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem 273:4928-4936.
31. Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, Ichijo H, Wimalasena J. 1999. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal Kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem 274:8208-8216.
32. Watanabe N, Iwamoto T, Dickinson DA, Iles KE, Forman HJ. 2002. Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase. Arch Biochem Biophys 405:231-240.
33. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL. 1998. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 18:2416-2429.
34. Willaime-Morawek S, Brami-Cherrier K, Mariani J, Caboche J, Brugg B. 2003. c-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 119:387-397.
35. 2/M. Mol Cell Biol 19:8469-8478.
36. Yu CR, Rahmani M, Dent P, Grant S. 2004. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. Exp Cell Res 295:555-566.
37. Yuan YJ, Ge ZQ, Li JC. 2002. Differentiation of apoptotic and necrototic cells in suspension cultures of Taxus cuspidata by the combined use of fluorescent dying and histochemical staining. Biotech Lett 24:71-76.